UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interobserver variation in the classification of tumor deposits in rectal cancer—is the use of histopathological characteristics the way to go?

Virchows Archiv : an international journal of pathology, 2021-12, Vol.479 (6), p.1111-1118

2021

Volltextzugriff (PDF)

Ex vivo specimen MRI and pathology confirm a rectosigmoid mesenteric waist at the junction of the mesorectum and mesocolon

Colorectal disease, 2020-02, Vol.22 (2), p.212-218

2020

Volltextzugriff (PDF)

PARAGON II – A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer

European journal of surgical oncology, 2016-12, Vol.42 (12), p.1866-1872

2016

Volltextzugriff (PDF)

Radical resection of large metastatic non-functioning pancreatic neuroendocrine carcinoma complicated by splenic vein thrombosis and sinistral portal hypertension

International journal of surgery case reports, 2021-04, Vol.81, p.105724, Article 105724

2021

Volltextzugriff (PDF)

Circulating tumour DNA (ctDNA) as a tool to assess response and guide therapy adaptation in rectal cancer

Annals of oncology, 2018-10, Vol.29, p.viii661-viii661

2018

Volltextzugriff (PDF)

Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE

ESMO open, 2024-04, Vol.9 (4), p.102971-102971, Article 102971

2024

Volltextzugriff (PDF)

Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases

European journal of surgical oncology, 2010-01, Vol.36 (1), p.52-57

2010

Volltextzugriff (PDF)

378. How does Ki-67 status influence outcomes for resectable neuroendocrine liver metastases?

European journal of surgical oncology, 2014-11, Vol.40 (11), p.S146-S146

2014

Volltextzugriff (PDF)

Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study

Cancer chemotherapy and pharmacology, 2013-08, Vol.72 (2), p.359-368

2013

Volltextzugriff (PDF)

Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI® ) for colorectal liver metastases does not predict tumour destruction or long-term outcome

European journal of surgical oncology, 2013-10, Vol.39 (10), p.1122-1128

2013

Volltextzugriff (PDF)

Tumour size and differentiation predict survival after liver resection for hepatocellular carcinoma arising from non-cirrhotic and non-fibrotic liver: A case-controlled study

International journal of surgery (London, England), 2013-01, Vol.11 (10), p.1078-1082

2013

Volltextzugriff (PDF)

6064 POSTER Neoadjuvant Trans-arterial Chemo-embolization Using Irinotecan Beads for Easily Resectable Colorectal Liver Metastases – a Phase II Study

European journal of cancer (1990), 2011, Vol.47, p.S410-S410

2011

Volltextzugriff (PDF)

OP-20 Radiological response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI®) for resectable liver metastases from colorectal cancer does not correlate with pathological response or long-term outcome

Digestive and liver disease, 2013-04, Vol.45, p.S255-S255

2013

Volltextzugriff (PDF)

2502 POSTER Microwave Ablation of Ex Vivo Human Liver and Colorectal Liver Metastases With a Novel 14.5 GHz Generator

European journal of cancer (1990), 2011, Vol.47, p.S217-S218

2011

Volltextzugriff (PDF)

124P Acquired resistance to first-line chemo- and EGFRab-therapy in mCRC: Biopsy analysis of the iSCORE trial

Annals of oncology, 2024-06, Vol.35, p.S58-S58

2024

Volltextzugriff (PDF)

Robotic Celiac Artery Resection with Distal Pancreatic Splenectomy Following Common Hepatic Artery Ligation. A Novel Approach to Pancreatic Cancer Encasing Celiac Axis

HPB (Oxford, England), 2023, Vol.25, p.S415-S416

2023

Volltextzugriff (PDF)

Renal cell carcinoma metastases to gallbladder

Annals of the Royal College of Surgeons of England, 2013-11, Vol.95 (8), p.e136-138

2013

Volltextzugriff (PDF)

Pre-operative liver enzyme predicts survival and recurrence after liver resection for hepatocellular carcinoma arising from non-cirrhotic/non-fibrotic liver: A European perspective

International journal of surgery (London, England), 2013-10, Vol.11 (8), p.642-643

2013

Volltextzugriff (PDF)

Renal cell carcinoma metastases to gallbladder

Annals of the Royal College of Surgeons of England, 2013-11, Vol.95 (8), p.e7-e9

2013

Volltextzugriff (PDF)

Feasibility of neoadjuvant trans-arterial chemo-embolization (TACE) using irinotecan beads (DEBIRI) before hepatectomy (HPX) for easily resectable colorectal liver metastases (RCLM): A Phase II study

European journal of surgical oncology, 2010, Vol.36 (11), p.1101-1101

2010

Volltextzugriff (PDF)

P-111 PD1 and LAG3 inhibition as second+ line treatment after EGFR antibody-containing therapy in RAS/BRAF wildtype, MMRp metastatic colorectal cancer

Annals of oncology, 2023-06, Vol.34, p.S53-S54

2023

Volltextzugriff (PDF)

PD-2 EMERGE: A multi-centre, non-randomised, single-arm phase II study investigating domatinostat plus avelumab in patients with previously treated advanced mismatch repair-proficient oesophagogastric and colorectal adenocarcinoma

Annals of oncology, 2022-06, Vol.33, p.S239

2022

Volltextzugriff (PDF)

Are obesity (expressed as body mass index [BMI] = 25kg/m2) and hepatic steatosis contraindications to patients undergoing hepatectomy for colorectal liver metastases (CRLM)?

European journal of surgical oncology, 2008, Vol.34 (10), p.1169-1169

2008

Volltextzugriff (PDF)

1867PCirculating tumour DNA (ctDNA) as a tool to assess response and guide therapy adaptation in rectal cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(35)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(16)
Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Female
(11)
Surgery
(11)
Male
(9)
Aged
(8)
Hematology, Oncology And Palliative Medicine
(8)
Middle Aged
(8)
Oncology
(6)
Adult
(4)
Colorectal Neoplasms - Pathology
(4)
Gastroenterology & Hepatology
(4)
Liver
(4)
Liver Neoplasms - Secondary
(4)
Metastases
(4)
Neoadjuvant Therapy
(4)
Treatment Outcome
(4)
Tumors
(4)
Antineoplastic Agents, Phytogenic - Administration & Dosage
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Interobserver variation in the classification of tumor deposits in rectal cancer—is the use of histopathological characteristics the way to go?

Ex vivo specimen MRI and pathology confirm a rectosigmoid mesenteric waist at the junction of the mesorectum and mesocolon

PARAGON II – A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer

Radical resection of large metastatic non-functioning pancreatic neuroendocrine carcinoma complicated by splenic vein thrombosis and sinistral portal hypertension

Circulating tumour DNA (ctDNA) as a tool to assess response and guide therapy adaptation in rectal cancer

Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE

Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases

378. How does Ki-67 status influence outcomes for resectable neuroendocrine liver metastases?

Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study

Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI® ) for colorectal liver metastases does not predict tumour destruction or long-term outcome

Tumour size and differentiation predict survival after liver resection for hepatocellular carcinoma arising from non-cirrhotic and non-fibrotic liver: A case-controlled study

6064 POSTER Neoadjuvant Trans-arterial Chemo-embolization Using Irinotecan Beads for Easily Resectable Colorectal Liver Metastases – a Phase II Study

OP-20 Radiological response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI®) for resectable liver metastases from colorectal cancer does not correlate with pathological response or long-term outcome

2502 POSTER Microwave Ablation of Ex Vivo Human Liver and Colorectal Liver Metastases With a Novel 14.5 GHz Generator

124P Acquired resistance to first-line chemo- and EGFRab-therapy in mCRC: Biopsy analysis of the iSCORE trial

Robotic Celiac Artery Resection with Distal Pancreatic Splenectomy Following Common Hepatic Artery Ligation. A Novel Approach to Pancreatic Cancer Encasing Celiac Axis

Renal cell carcinoma metastases to gallbladder

Pre-operative liver enzyme predicts survival and recurrence after liver resection for hepatocellular carcinoma arising from non-cirrhotic/non-fibrotic liver: A European perspective

Renal cell carcinoma metastases to gallbladder

Feasibility of neoadjuvant trans-arterial chemo-embolization (TACE) using irinotecan beads (DEBIRI) before hepatectomy (HPX) for easily resectable colorectal liver metastases (RCLM): A Phase II study

P-111 PD1 and LAG3 inhibition as second+ line treatment after EGFR antibody-containing therapy in RAS/BRAF wildtype, MMRp metastatic colorectal cancer

PD-2 EMERGE: A multi-centre, non-randomised, single-arm phase II study investigating domatinostat plus avelumab in patients with previously treated advanced mismatch repair-proficient oesophagogastric and colorectal adenocarcinoma

Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom

Are obesity (expressed as body mass index [BMI] = 25kg/m2) and hepatic steatosis contraindications to patients undergoing hepatectomy for colorectal liver metastases (CRLM)?

1867PCirculating tumour DNA (ctDNA) as a tool to assess response and guide therapy adaptation in rectal cancer

Suchergebnisse filtern